Johnson & Johnson vs Merck & Co., Inc.
Johnson & Johnson is worth $650.673B, 1.7× the $377.724B market cap of Merck & Co., Inc.. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $650.673B | $377.724B |
| Global rank | #1 | #2 |
| Share price | $270.00 | $153.10 |
| Change | +3.93% | +17.39% |
| Revenue | $94.193B | $65.011B |
| Net income | $26.804B | $18.254B |
| Country | United States | United States |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Johnson & Johnson bigger than Merck & Co., Inc.?
- Johnson & Johnson has a market cap of $650.673B against $377.724B for Merck & Co., Inc., making it 1.7 times as valuable.
- Which company earns more, JNJ or MRK?
- Johnson & Johnson reported net income of $26.804B and Merck & Co., Inc. reported $18.254B in their most recent annual periods.